A Woman-to-Woman Approach to Increasing Knowledge about Gynecologic Cancer: CDC’s Inside Knowledge Campaign Cynthia A. Gelb, BSJ , Lindsey Polonec, MA , Jennifer Chu, MPH , Jennifer Wayman, MHS , Stephanie Mui, BA and

First Page		Document Content
Date: 2014-10-31 09:26:31 Gynecologic oncology Ovarian cancer Ovarian Cancer National Alliance Vaginal cancer Cervical cancer Vulvar cancer Breast cancer Cancer Endometrial cancer Medicine Gynaecological cancer Oncology		A Woman-to-Woman Approach to Increasing Knowledge about Gynecologic Cancer: CDC’s Inside Knowledge Campaign Cynthia A. Gelb, BSJ , Lindsey Polonec, MA , Jennifer Chu, MPH , Jennifer Wayman, MHS , Stephanie Mui, BA and Add to Reading List Source URL: www.cdc.gov Download Document from Source Website File Size: 2,61 MB Share Document on Facebook

	Journal of Machine Learning ResearchSubmitted 8/15; Revised 3/16; PublishedStructure-Leveraged Methods in Breast Cancer Risk Prediction DocID: 1vq0d - View Document
	Multicausality: Confounding - Assignment solutions 1. a. Reserpine is a risk factor. Overall, the incidence of breast cancer isper 100,000 women-years in reserpine users and 6.14 per 100,000 women-years in nonuser DocID: 1vpNA - View Document
	Frequently Asked Questions: Trainees seeking a PhD education in Cancer Biology or a related area with a focus on Breast Cancer Health Disparities. 1. What is the Komen Graduate Training in Disparities Research Grant (GT DocID: 1voV1 - View Document
	_____________________________________________________________ What to Do When Someone You Know Has Been Diagnosed with Breast Cancer [Last revised Mar 2014] DocID: 1vlqg - View Document
	Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1–mediated metabolism to the product 4′ hydroxy tangeretin DocID: 1vl9e - View Document